Funds cross-border research to pilot and implement AI-enhanced prostate cancer screening across the EU, aiming to improve early detection and reduce diagnostic disparities.
European Commission has archived this opportunity.
Funder: European Commission
Due Dates: January 6, 2026 (Full application deadline, 17:00 Brussels time)
Funding Amounts: €7,440,000 total call budget; typical project funding expected in the €2–4M range; project duration varies by proposal.
Summary: Funds the piloting and implementation of prostate cancer screening programmes in EU Member States, with a focus on integrating AI-based technologies to improve early detection and reduce disparities.
Key Information: Proposals must include cross-border collaboration, AI integration, and align with EU guidelines and Council Recommendations.
This grant, under the EU4Health Programme (EU4H-2026-SANTE-PJ-03), supports the piloting and implementation of prostate cancer screening programmes across EU Member States. The focus is on integrating artificial intelligence (AI) technologies to enhance early detection, reduce disparities in access to diagnosis, and facilitate implementation research. Funded projects are expected to launch new pilot initiatives, monitor and assess ongoing studies, plan new studies based on identified gaps, and promote coordinated research and knowledge exchange across borders. The action also encourages the aggregation and analysis of prostate cancer imaging datasets for AI studies, connects relevant experts and patient organisations for dissemination, and promotes synergies with related European cancer screening initiatives and guidelines.